                         SEQUENCE LISTING

<110>  Ernst-Moritz-Arndt-Universitt Greifswald
 
<120>  Monoklonaler anti-Idiotyp-Antikrper Ganglidiomab

<130>  PVA-25393 WO

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  133
<212>  PRT
<213>  mus

<400>  1

Met Lys Leu Pro Val Arg Leu Leu Val Leu Met Phe Trp Ile Pro Gly 
1               5                   10                  15      


Ser Ser Ser Asp Val Leu Met Thr Gln Thr Pro Leu Ser Leu Pro Val 
            20                  25                  30          


Ser Leu Gly Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Ile 
        35                  40                  45              


Val His Ser Asn Gly Asp Thr Tyr Leu Glu Trp Phe Leu Gln Lys Pro 
    50                  55                  60                  


Gly Gln Ser Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe Ser 
65                  70                  75                  80  


Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
                85                  90                  95      


Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Tyr Cys 
            100                 105                 110         


Phe Gln Gly Ser His Val Pro Trp Thr Phe Gly Gly Gly Thr Lys Leu 
        115                 120                 125             


Glu Ile Lys Arg Ala 
    130             


<210>  2
<211>  399
<212>  DNA
<213>  mus

<400>  2
atgaagttgc ctgttaggct gttggtgctg atgttctgga ttcctggttc cagtagtgat       60

gttttgatga cccaaactcc actctccctg cctgtcagtc ttggagatca agcctccatc      120

tcttgcagat ctagtcagag cattgtacat agtaatggag acacctattt agaatggttc      180

ctgcagaaac caggccagtc tccaaagctc ctgatctaca aagtttccaa ccgattttct      240

ggggtcccag acaggttcag tggcagtgga tcagggacag atttcacact caagatcagc      300

agagtggagg ctgaggatct gggagtttat tactgctttc aaggttcaca tgttccgtgg      360

acgttcggtg gaggcaccaa gctggaaatc aaacgggct                             399


<210>  3
<211>  142
<212>  PRT
<213>  mus

<400>  3

Met Ala Val Leu Gly Leu Leu Phe Cys Leu Val Thr Phe Pro Ser Cys 
1               5                   10                  15      


Ile Leu Ser Gln Val Gln Leu Lys Glu Ser Gly Pro Gly Leu Val Ala 
            20                  25                  30          


Pro Ser Gln Ser Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Leu 
        35                  40                  45              


Ile Gly His Gly Val Asn Trp Val Arg Gln Pro Pro Gly Lys Gly Leu 
    50                  55                  60                  


Glu Trp Leu Gly Met Ile Trp Gly Asp Gly Ser Thr Asp Tyr Asn Ser 
65                  70                  75                  80  


Ala Leu Lys Ser Arg Leu Ser Ile Ser Lys Asp Asn Ser Lys Ser Gln 
                85                  90                  95      


Val Phe Leu Lys Met Asn Ser Leu Gln Thr Asp Asp Thr Ala Arg Tyr 
            100                 105                 110         


Tyr Cys Ala Arg Asp Gly Tyr His Ile Ser Leu Gly Gly Tyr Tyr Gly 
        115                 120                 125             


Leu Asp Tyr Trp Gly Gln Gly Thr Ser Val Thr Val Ser Ser 
    130                 135                 140         


<210>  4
<211>  426
<212>  DNA
<213>  mus

<400>  4
atggctgtct tggggctgct cttctgcctg gtaacattcc caagctgtat cctttcccag       60

gtgcagctga aggagtcagg acctggcctg gtggcgccct cacagagtct gtccattaca      120

tgcaccgtct cagggttctc attaatcggc catggtgtaa actgggttcg ccagcctcca      180

ggaaagggtc tggagtggct gggaatgata tggggtgatg gaagcacaga ctataattca      240

gctctcaaat ccagactgag catcagcaag gacaactcca agagccaagt tttcttaaaa      300

atgaacagtc tgcaaactga tgacacagcc aggtattact gtgccagaga tggttaccat      360

atttcccttg ggggttacta tggtttggac tactggggtc aaggaacctc agtcaccgtc      420

tcctca                                                                 426


